U.S. Markets closed

Research Report Identifies Cameco, American Equity Investment Life Holding, AG Mortgage Investment Trust, Arena Pharmaceuticals, Mimecast, and Aldeyra Therapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Cameco Corporation (CCJ), American Equity Investment Life Holding Company (AEL), AG Mortgage Investment Trust, Inc. (MITT), Arena Pharmaceuticals, Inc. (ARNA), Mimecast Limited (MIME), and Aldeyra Therapeutics, Inc. (ALDX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CCJ DOWNLOAD: http://MarketSourceResearch.com/register/?so=CCJ
AEL DOWNLOAD: http://MarketSourceResearch.com/register/?so=AEL
MITT DOWNLOAD: http://MarketSourceResearch.com/register/?so=MITT
ARNA DOWNLOAD: http://MarketSourceResearch.com/register/?so=ARNA
MIME DOWNLOAD: http://MarketSourceResearch.com/register/?so=MIME
ALDX DOWNLOAD: http://MarketSourceResearch.com/register/?so=ALDX

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Cameco Corporation (CCJ), American Equity Investment Life Holding Company (AEL), AG Mortgage Investment Trust, Inc. (MITT), Arena Pharmaceuticals, Inc. (ARNA), Mimecast Limited (MIME), and Aldeyra Therapeutics, Inc. (ALDX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 28th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

CAMECO CORPORATION (CCJ) REPORT OVERVIEW

Cameco's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cameco reported revenue of $373.24MM vs $387.46MM (down 3.67%) and analysts estimated basic earnings per share $0.05 vs -$0.25. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cameco reported revenue of $1,663.80MM vs $1,836.20MM (down 9.39%) and analysts estimated basic earnings per share -$0.40 vs -$0.12. Analysts expect earnings to be released on February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.36. The estimated EPS forecast for the next fiscal year is $0.24 and is expected to report on February 8th, 2019.

To read the full Cameco Corporation (CCJ) report, download it here: http://MarketSourceResearch.com/register/?so=CCJ

-----------------------------------------

AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY (AEL) REPORT OVERVIEW

American Equity Investment Life Holding's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, American Equity Investment Life Holding reported revenue of $1,193.74MM vs $905.95MM (up 31.77%) and analysts estimated basic earnings per share $1.87 vs $0.64 (up 192.19%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, American Equity Investment Life Holding reported revenue of $3,891.65MM vs $2,220.28MM (up 75.28%) and analysts estimated basic earnings per share $1.96 vs $0.98 (up 100.00%). Analysts expect earnings to be released on February 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.82. The estimated EPS forecast for the next fiscal year is $3.78 and is expected to report on February 6th, 2019.

To read the full American Equity Investment Life Holding Company (AEL) report, download it here: http://MarketSourceResearch.com/register/?so=AEL

-----------------------------------------

AG MORTGAGE INVESTMENT TRUST, INC. (MITT) REPORT OVERVIEW

AG Mortgage Investment Trust's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, AG Mortgage Investment Trust reported revenue of $39.70MM vs $33.59MM (up 18.19%) and analysts estimated basic earnings per share $0.70 vs $1.17 (down 40.17%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, AG Mortgage Investment Trust reported revenue of $128.85MM vs $123.01MM (up 4.75%) and analysts estimated basic earnings per share $3.77 vs $1.80 (up 109.44%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full AG Mortgage Investment Trust, Inc. (MITT) report, download it here: http://MarketSourceResearch.com/register/?so=MITT

-----------------------------------------

ARENA PHARMACEUTICALS, INC. (ARNA) REPORT OVERVIEW

Arena Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Arena Pharmaceuticals reported revenue of $3.57MM vs $2.42MM (up 47.95%) and basic earnings per share -$0.70 vs -$0.86. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Arena Pharmaceuticals reported revenue of $21.34MM vs $92.16MM (down 76.85%) and analysts estimated basic earnings per share -$2.77 vs -$0.93. Analysts expect earnings to be released on March 13th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.36. The estimated EPS forecast for the next fiscal year is -$3.21 and is expected to report on March 13th, 2019.

To read the full Arena Pharmaceuticals, Inc. (ARNA) report, download it here: http://MarketSourceResearch.com/register/?so=ARNA

-----------------------------------------

MIMECAST LIMITED (MIME) REPORT OVERVIEW

Mimecast's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Mimecast reported revenue of $82.17MM vs $63.07MM (up 30.29%) and analysts estimated basic earnings per share -$0.03 vs -$0.02. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Mimecast reported revenue of $261.90MM vs $186.56MM (up 40.38%) and analysts estimated basic earnings per share -$0.22 vs -$0.10. Analysts expect earnings to be released on February 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $0.16 and is expected to report on May 13th, 2019.

To read the full Mimecast Limited (MIME) report, download it here: http://MarketSourceResearch.com/register/?so=MIME

-----------------------------------------

ALDEYRA THERAPEUTICS, INC. (ALDX) REPORT OVERVIEW

Aldeyra Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on April 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.37. The estimated EPS forecast for the next fiscal year is -$1.73 and is expected to report on April 4th, 2019.

To read the full Aldeyra Therapeutics, Inc. (ALDX) report, download it here: http://MarketSourceResearch.com/register/?so=ALDX

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.